158 related articles for article (PubMed ID: 29322935)
21. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
Chitale D; Gong Y; Taylor BS; Broderick S; Brennan C; Somwar R; Golas B; Wang L; Motoi N; Szoke J; Reinersman JM; Major J; Sander C; Seshan VE; Zakowski MF; Rusch V; Pao W; Gerald W; Ladanyi M
Oncogene; 2009 Aug; 28(31):2773-83. PubMed ID: 19525976
[TBL] [Abstract][Full Text] [Related]
22. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
[TBL] [Abstract][Full Text] [Related]
24. Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects.
Jhanwar SC; Xu XL; Elahi AH; Abramson DH
Adv Biol Regul; 2020 Dec; 78():100723. PubMed ID: 32992231
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
Liu J; Liu Y
Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773
[TBL] [Abstract][Full Text] [Related]
26. High-resolution detection of recurrent aberrations in lung adenocarcinomas by array comparative genomic hybridization and expression analysis of selective genes by quantitative PCR.
Zhu H; Wong MP; Tin V
Int J Oncol; 2014 Jun; 44(6):2068-76. PubMed ID: 24728343
[TBL] [Abstract][Full Text] [Related]
27. Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers.
Cohen AL; Piccolo SR; Cheng L; Soldi R; Han B; Johnson WE; Bild AH
BMC Med Genomics; 2013 Sep; 6():35. PubMed ID: 24079712
[TBL] [Abstract][Full Text] [Related]
28. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning.
Hosgood HD; Pao W; Rothman N; Hu W; Pan YH; Kuchinsky K; Jones KD; Xu J; Vermeulen R; Simko J; Lan Q
Respir Med; 2013 Nov; 107(11):1755-62. PubMed ID: 24055406
[TBL] [Abstract][Full Text] [Related]
29. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
[TBL] [Abstract][Full Text] [Related]
30. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
[TBL] [Abstract][Full Text] [Related]
31. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
Shigematsu H; Takahashi T; Nomura M; Majmudar K; Suzuki M; Lee H; Wistuba II; Fong KM; Toyooka S; Shimizu N; Fujisawa T; Minna JD; Gazdar AF
Cancer Res; 2005 Mar; 65(5):1642-6. PubMed ID: 15753357
[TBL] [Abstract][Full Text] [Related]
32. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
33. MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.
Boland JM; Jang JS; Li J; Lee AM; Wampfler JA; Erickson-Johnson MR; Soares I; Yang P; Jen J; Oliveira AM; Yi ES
J Thorac Oncol; 2013 May; 8(5):574-81. PubMed ID: 23449277
[TBL] [Abstract][Full Text] [Related]
34. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
[TBL] [Abstract][Full Text] [Related]
35. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
Yuan S; Yu SL; Chen HY; Hsu YC; Su KY; Chen HW; Chen CY; Yu CJ; Shih JY; Chang YL; Cheng CL; Hsu CP; Hsia JY; Lin CY; Wu G; Liu CH; Wang CD; Yang KC; Chen YW; Lai YL; Hsu CC; Lin TC; Yang TY; Chen KC; Hsu KH; Chen JJ; Chang GC; Li KC; Yang PC
J Clin Oncol; 2011 Sep; 29(25):3435-42. PubMed ID: 21810691
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations.
Lan Y; Liu W; Zhang W; Hu J; Zhu X; Wan L; A S; Ping Y; Xiao Y
Cancer Med; 2021 Jul; 10(14):4977-4993. PubMed ID: 34076361
[TBL] [Abstract][Full Text] [Related]
37. Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.
Thu KL; Vucic EA; Chari R; Zhang W; Lockwood WW; English JC; Fu R; Wang P; Feng Z; MacAulay CE; Gazdar AF; Lam S; Lam WL
PLoS One; 2012; 7(3):e33003. PubMed ID: 22412972
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
[TBL] [Abstract][Full Text] [Related]
39. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
Balko JM; Potti A; Saunders C; Stromberg A; Haura EB; Black EP
BMC Genomics; 2006 Nov; 7():289. PubMed ID: 17096850
[TBL] [Abstract][Full Text] [Related]
40. Characterizing the cancer genome in lung adenocarcinoma.
Weir BA; Woo MS; Getz G; Perner S; Ding L; Beroukhim R; Lin WM; Province MA; Kraja A; Johnson LA; Shah K; Sato M; Thomas RK; Barletta JA; Borecki IB; Broderick S; Chang AC; Chiang DY; Chirieac LR; Cho J; Fujii Y; Gazdar AF; Giordano T; Greulich H; Hanna M; Johnson BE; Kris MG; Lash A; Lin L; Lindeman N; Mardis ER; McPherson JD; Minna JD; Morgan MB; Nadel M; Orringer MB; Osborne JR; Ozenberger B; Ramos AH; Robinson J; Roth JA; Rusch V; Sasaki H; Shepherd F; Sougnez C; Spitz MR; Tsao MS; Twomey D; Verhaak RG; Weinstock GM; Wheeler DA; Winckler W; Yoshizawa A; Yu S; Zakowski MF; Zhang Q; Beer DG; Wistuba II; Watson MA; Garraway LA; Ladanyi M; Travis WD; Pao W; Rubin MA; Gabriel SB; Gibbs RA; Varmus HE; Wilson RK; Lander ES; Meyerson M
Nature; 2007 Dec; 450(7171):893-8. PubMed ID: 17982442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
